NWBO · Northwest Biotherapeutics Inc
$0.16
-0.01 (-6.92%)
At close · Jul 29
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of recurring operating losses and operating cash flow deficits, there is substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date of this filing.”View the 10-Q filed May 15, 2026
Market Cap
$282.49M
Shares
1.64B
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2015-12-31 | $0 | 10-K, filed 2016-03-16 |
| 2014-12-31 | $0 | 10-K, filed 2016-03-16 |
| 2013-12-31 | $240,000 | 10-K, filed 2016-03-16 |